Abstract
Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Current Bioinformatics
Title:Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems
Volume: 7 Issue: 3
Author(s): Alejandro Rodriguez-Gonzalez, Gandhi Hernandez-Chan, Ricardo Colomo-Palacios, Juan Miguel Gomez-Berbis, Angel Garcia-Crespo, Giner Alor-Hernandez and Rafael Valencia-Garcia
Affiliation:
Keywords: Knowledge representation, medical diagnosis, ontology, Semantic web, Healthcare, in diagnostic decision support systems, OBO-Foundry, SNOMED-CT, DDxOnt, Interoperability Database.
Abstract: Healthcare has played a main role in the Semantic Web (SW) field given the knowledge representation possibilities that SW is capable of addressing. Nowadays there are a large number of ontologies which can be used for several domains of healthcare (genetics, proteins, cellular components, anatomy, and specific diseases among others). However, in some cases, the definition and population of these ontologies are not enough to be used in concrete domains. In this paper we provide the design of a set of ontologies for their direct use in diagnostic decision support systems. We have designed an ontology modular architecture where main (root) ontology is created to define the main relations which can be found in the aforementioned domain. A set of subsumed ontologies has also been designed following some principles of OBO-Foundry and using SNOMED-CT terminology as the main interoperability component. These ontologies have been also designed trying to create them as light as possible. The evaluation of the designed ontology is based on a set of quantitative aspects which aims to show the main principles which should be followed in the process of design ontologies for the domain of differential diagnosis.
Export Options
About this article
Cite this article as:
Rodriguez-Gonzalez Alejandro, Hernandez-Chan Gandhi, Colomo-Palacios Ricardo, Miguel Gomez-Berbis Juan, Garcia-Crespo Angel, Alor-Hernandez Giner and Valencia-Garcia Rafael, Towards an Ontology to Support Semantics Enabled Diagnostic Decision Support Systems, Current Bioinformatics 2012; 7 (3) . https://dx.doi.org/10.2174/157489312802460721
DOI https://dx.doi.org/10.2174/157489312802460721 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Antimitotic Potential of PARP Inhibitors, An Unexplored Therapeutic Alternative
Current Topics in Medicinal Chemistry Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
Current Medicinal Chemistry Modulation of the Cell Cycle and Induction of Apoptosis in Human Cancer Cells by Synthetic Bile Acids
Current Cancer Drug Targets Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry (Neuro)Transmitter Systems in Circulating Immune Cells: A Target of Immunopharmacological Interventions?
Current Medicinal Chemistry Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy
Current Drug Targets CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Gene Expression Profiling in Rodent Models for Schizophrenia
Current Neuropharmacology Peptides Targeting Estrogen Receptor Alpha-Potential Applications for Breast Cancer Treatment
Current Pharmaceutical Design Telomerase and Survivin in Colorectal and Pancreatic Cancer – Biomarkers of Life and Death in the Balance Between Proliferation and Apoptosis
Current Cancer Therapy Reviews Analytical Methods of Bioactive Metabolites Produced by Plants and Microorganisms
Current Pharmaceutical Analysis Advances in the Management of Malignant Hemopathies: The Role of Statins
Recent Patents on DNA & Gene Sequences QSPR and Flow Cytometry Analysis (QSPR-FCA): Review and New Findings on Parallel Study of Multiple Interactions of Chemical Compounds with Immune Cellular and Molecular Targets
Current Drug Metabolism Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Current Cancer Therapy Reviews A Steroidal Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitor Triggers Pro-apoptotic Signaling and Induces Apoptosis in Prostate and Lung Tumor Cells
Anti-Cancer Agents in Medicinal Chemistry Telomerase Inhibitors: Potential Anticancer Agents
Mini-Reviews in Organic Chemistry Small Molecules for Immunomodulation in Cancer: A Review
Anti-Cancer Agents in Medicinal Chemistry Inhibiting the “Undruggable” RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products
Current Medicinal Chemistry Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Current Topics in Medicinal Chemistry